Stocks · News reference
Mesa Laboratories (NASDAQ:MLAB) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $0.03 by 8833.33 percent. This is a 15.52 percent increase over earnings of $2.32 per share
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Mesa Laboratories, Inc. (NASDAQ: MLAB) ("Mesa," "we," "us" or "our"), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today
Filed: 2026-10-13 AccNo: 0001437749-26-032499 Size: 184 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $94 to $110.